Poland – Pharmaceutical products – Supplies of pharmaceutical products (REPEATED)

Opportunity description

I. DESCRIPTION OF THE SUBJECT MATTER OF THE CONTRACT 1. The subject matter of the contract is the supply of pharmaceutical products, divided into 4 tasks (packages), in accordance with the quantities and requirements contained in Appendix No. 3 to this specification, “OPZ - Assortment and Price Form”, a) partial tenders may be submitted for individual tasks (packages); b) the partial selection of tenders is reserved, where a part constitutes an individual task (package); c) tenders that do not contain the full scope of the subject matter of the contract specified in Appendix No. 3 to the specification for individual tasks (packages) will be rejected; d) the Contractor may submit tenders for one, several or all tasks (packages). 2. Additional conditions concerning the subject matter of the contract: a) the unit price of a medicine included on the list of reimbursed medicines may not be higher than that resulting from the provision of Article 9(2) of the Act of 12 May 2011 on the reimbursement of medicines, foodstuffs intended for particular nutritional uses and medical devices (Journal of Laws of 2026, item 253), b) the Contracting Authority consents to changes in package sizes (tablets, ampoules, kilograms, etc.) with appropriate conversion and rounding up to full packages (subject to the reservation indicated in the SWZ), c) All proper names of products, standards and certificates referred to in the specification serve to define the desired standard of performance and the properties and requirements assumed for the subject matter of the contract. In this case, the Contracting Authority permits the use of equivalent solutions, provided that they meet all the Contracting Authority’s requirements. d) The quality requirements for medicinal products are specified in the Act of 6 September 2001, Pharmaceutical Law (Journal of Laws of 2025, item 750, as amended), which in Article 1(1)(1) stipulates that it defines, inter alia, the principles and procedure for authorising medicinal products for marketing, taking particular account of the requirements concerning their quality, efficacy and safety of use". Furthermore, the Regulation of the Minister of Health of 9 November 2015 on Good Manufacturing Practice requirements (Journal of Laws of 2022, item 1273, as subsequently amended) specifies in detail the requirements for ensuring the appropriate quality of a medicinal product. In the present procedure, the quality standard of medicinal products was defined by the Contracting Authority by providing it in the description of the subject matter of the contract, which includes, inter alia: composition, form and route of administration, and unit of measurement. 3. Common Procurement Vocabulary (CPV): 33.60.00.00-6 Pharmaceutical products Supplies of pharmaceutical products. A detailed description of the subject matter of the contract is provided in Appendix No. 3 to the SWZ. Procedure: open. Review the original TED notice for the complete requirement, lots, amendments and attachments.